+262.4%
ZETA vs GSK
+50.1%
+212.3%
-70.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.1% | -1.6% | -3.6% | -5.0% |
| 7D | -13.5% | -4.7% | -8.8% | -13.2% |
| 30D | -4.0% | -4.7% | +0.7% | -3.6% |
| 3M | +11.9% | -8.8% | +20.7% | +12.8% |
| 6M | +76.1% | -4.6% | +80.7% | +76.6% |
| YTD | +58.3% | +1.0% | +57.3% | +56.7% |
| 1Y | +90.9% | +6.9% | +84.0% | +87.4% |
| 3Y | +280.4% | +52.5% | +227.9% | +252.6% |
| 5Y | +281.8% | +40.3% | +241.5% | +253.3% |
| All | +262.4% | +50.1% | +212.3% | +242.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling